During the past decade, Vermont Cancer Center at Fletcher Allen Health Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vermont Cancer Center at Fletcher Allen Health Care" are "Cancer" (1 trials) and "Thyroid Cancer" (1 trials). Many other conditions were trialed in "Vermont Cancer Center at Fletcher Allen Health Care" in a lesser frequency.

Most popular intervention types in "Vermont Cancer Center at Fletcher Allen Health Care" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "XL184" (1 trials) and "dalteparin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vermont Cancer Center at Fletcher Allen Health Care" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Vermont Cancer Center at Fletcher Allen Health Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Vermont Cancer Center at Fletcher Allen Health Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vermont Cancer Center at Fletcher Allen Health Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".